IDXX logo

IDEXX Laboratories, Inc. (IDXX) Accounts receivable

Annual accounts receivable:

$534.33M+$21.77M(+4.25%)
December 31, 2024

Summary

  • As of today (August 25, 2025), IDXX annual accounts receivable is $534.33 million, with the most recent change of +$21.77 million (+4.25%) on December 31, 2024.
  • During the last 3 years, IDXX annual accounts receivable has risen by +$128.21 million (+31.57%).
  • IDXX annual accounts receivable is now at all-time high.

Performance

IDXX Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDXXbalance sheet metrics

Quarterly accounts receivable:

$628.47M+$38.08M(+6.45%)
June 30, 2025

Summary

  • As of today (August 25, 2025), IDXX quarterly accounts receivable is $628.47 million, with the most recent change of +$38.08 million (+6.45%) on June 30, 2025.
  • Over the past year, IDXX quarterly accounts receivable has increased by +$36.15 million (+6.10%).
  • IDXX quarterly accounts receivable is now at all-time high.

Performance

IDXX Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDXXbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

IDXX Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.3%+6.1%
3 y3 years+31.6%+38.7%
5 y5 years+86.2%+85.3%

IDXX Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+31.6%at high+46.0%
5 y5-yearat high+86.2%at high+85.3%
alltimeall timeat high+1069.5%at high+1275.5%

IDXX Accounts receivable History

DateAnnualQuarterly
Jun 2025
-
$628.47M(+6.4%)
Mar 2025
-
$590.40M(+10.5%)
Dec 2024
$534.33M(+4.2%)
$534.33M(-6.7%)
Sep 2024
-
$572.67M(-3.3%)
Jun 2024
-
$592.32M(+5.1%)
Mar 2024
-
$563.78M(+10.0%)
Dec 2023
$512.56M(+15.8%)
$512.56M(+1.8%)
Sep 2023
-
$503.65M(-1.6%)
Jun 2023
-
$511.98M(+3.9%)
Mar 2023
-
$492.67M(+11.3%)
Dec 2022
$442.47M(+9.0%)
$442.47M(+2.8%)
Sep 2022
-
$430.33M(-5.1%)
Jun 2022
-
$453.26M(+2.1%)
Mar 2022
-
$443.87M(+9.3%)
Dec 2021
$406.12M(+14.3%)
$406.12M(-0.5%)
Sep 2021
-
$408.21M(-0.4%)
Jun 2021
-
$410.00M(+0.4%)
Mar 2021
-
$408.39M(+15.0%)
Dec 2020
$355.27M(+23.8%)
$355.27M(-0.8%)
Sep 2020
-
$357.95M(+5.5%)
Jun 2020
-
$339.18M(+6.4%)
Mar 2020
-
$318.65M(+11.0%)
Dec 2019
$286.97M(+15.3%)
$286.97M(+1.2%)
Sep 2019
-
$283.54M(-5.2%)
Jun 2019
-
$299.16M(+2.2%)
Mar 2019
-
$292.83M(+17.7%)
Dec 2018
$248.85M(+6.1%)
$248.85M(-5.9%)
Sep 2018
-
$264.56M(-0.2%)
Jun 2018
-
$265.01M(+2.0%)
Mar 2018
-
$259.87M(+10.8%)
Dec 2017
$234.60M(+14.7%)
$234.60M(+2.8%)
Sep 2017
-
$228.16M(-5.0%)
Jun 2017
-
$240.26M(+6.6%)
Mar 2017
-
$225.35M(+10.2%)
Dec 2016
$204.49M(+8.6%)
$204.49M(-0.1%)
Sep 2016
-
$204.70M(-3.5%)
Jun 2016
-
$212.23M(+0.1%)
Mar 2016
-
$212.07M(+12.6%)
Dec 2015
$188.32M(+23.6%)
$188.32M(-1.4%)
Sep 2015
-
$190.90M(-4.3%)
Jun 2015
-
$199.44M(+1.6%)
Mar 2015
-
$196.23M(+28.8%)
Dec 2014
$152.38M(-3.6%)
$152.38M(-5.0%)
Sep 2014
-
$160.47M(-4.8%)
Jun 2014
-
$168.64M(-6.3%)
Mar 2014
-
$179.92M(+13.8%)
Dec 2013
$158.04M
$158.04M(+4.3%)
Sep 2013
-
$151.57M(-4.7%)
Jun 2013
-
$159.12M(+0.1%)
DateAnnualQuarterly
Mar 2013
-
$158.99M(+14.9%)
Dec 2012
$138.32M(-2.1%)
$138.32M(-2.2%)
Sep 2012
-
$141.37M(-3.9%)
Jun 2012
-
$147.16M(-8.6%)
Mar 2012
-
$160.98M(+13.9%)
Dec 2011
$141.28M(+17.7%)
$141.28M(+4.7%)
Sep 2011
-
$134.92M(-9.6%)
Jun 2011
-
$149.31M(+8.6%)
Mar 2011
-
$137.55M(+14.5%)
Dec 2010
$120.08M(+4.3%)
$120.08M(-0.3%)
Sep 2010
-
$120.45M(-5.3%)
Jun 2010
-
$127.14M(-2.6%)
Mar 2010
-
$130.52M(+13.4%)
Dec 2009
$115.11M(+3.2%)
$115.11M(-0.0%)
Sep 2009
-
$115.14M(-3.1%)
Jun 2009
-
$118.78M(+3.1%)
Mar 2009
-
$115.25M(+3.4%)
Dec 2008
$111.50M(+2.9%)
$111.50M(-0.5%)
Sep 2008
-
$112.05M(-7.1%)
Jun 2008
-
$120.56M(-3.7%)
Mar 2008
-
$125.25M(+15.6%)
Dec 2007
$108.38M(+33.2%)
$108.38M(+4.8%)
Sep 2007
-
$103.41M(-3.1%)
Jun 2007
-
$106.68M(+1.8%)
Mar 2007
-
$104.79M(+28.8%)
Dec 2006
$81.39M(+13.5%)
$81.39M(+2.6%)
Sep 2006
-
$79.30M(-6.1%)
Jun 2006
-
$84.47M(+3.1%)
Mar 2006
-
$81.92M(+14.3%)
Dec 2005
$71.69M(+9.2%)
$71.69M(+5.3%)
Sep 2005
-
$68.10M(-6.9%)
Jun 2005
-
$73.14M(-3.3%)
Mar 2005
-
$75.62M(+15.2%)
Dec 2004
$65.64M(+21.6%)
$65.64M(+13.3%)
Sep 2004
-
$57.95M(-2.3%)
Jun 2004
-
$59.29M(-3.5%)
Mar 2004
-
$61.47M(+13.9%)
Dec 2003
$53.98M(+18.1%)
$53.98M(+6.5%)
Sep 2003
-
$50.67M(-0.2%)
Jun 2003
-
$50.78M(-1.5%)
Mar 2003
-
$51.58M(+12.9%)
Dec 2002
$45.69M(-10.0%)
$45.69M(-4.0%)
Sep 2002
-
$47.61M(-0.8%)
Jun 2002
-
$48.00M(-7.1%)
Mar 2002
-
$51.68M(+1.8%)
Dec 2001
$50.77M(-11.3%)
$50.77M(-6.0%)
Sep 2001
-
$53.99M(-4.4%)
Jun 2001
-
$56.48M(-0.6%)
Mar 2001
-
$56.84M(-0.7%)
Dec 2000
$57.27M
$57.27M

FAQ

  • What is IDEXX Laboratories, Inc. annual accounts receivable?
  • What is the all time high annual accounts receivable for IDEXX Laboratories, Inc.?
  • What is IDEXX Laboratories, Inc. annual accounts receivable year-on-year change?
  • What is IDEXX Laboratories, Inc. quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for IDEXX Laboratories, Inc.?
  • What is IDEXX Laboratories, Inc. quarterly accounts receivable year-on-year change?

What is IDEXX Laboratories, Inc. annual accounts receivable?

The current annual accounts receivable of IDXX is $534.33M

What is the all time high annual accounts receivable for IDEXX Laboratories, Inc.?

IDEXX Laboratories, Inc. all-time high annual accounts receivable is $534.33M

What is IDEXX Laboratories, Inc. annual accounts receivable year-on-year change?

Over the past year, IDXX annual accounts receivable has changed by +$21.77M (+4.25%)

What is IDEXX Laboratories, Inc. quarterly accounts receivable?

The current quarterly accounts receivable of IDXX is $628.47M

What is the all time high quarterly accounts receivable for IDEXX Laboratories, Inc.?

IDEXX Laboratories, Inc. all-time high quarterly accounts receivable is $628.47M

What is IDEXX Laboratories, Inc. quarterly accounts receivable year-on-year change?

Over the past year, IDXX quarterly accounts receivable has changed by +$36.15M (+6.10%)
On this page